Theranos Inc. said it will shut down its blood-testing facilities and shrink its workforce by more than 40%. The moves mark a dramatic retreat by the Palo Alto, Calif., company and founder Elizabeth Holmes from their core strategy of offering a long menu of low-price blood tests directly to consumers. Those ambitions already were endangered by crippling regulatory sanctions that followed revelations by The Wall Street Journal of...

Source: Wall Street Journal October 06, 2016 00:22 UTC